LN Robotics Wins Johnson & Johnson’s ‘Korea Innovation QuickFire Challenge’
- 2024.12.13
- Awarded for ‘AVIAR,’ the first domestically developed robotic assistant for coronary intervention, and its core technology
- Recognized for the creative integration of AI and technological differentiation from competitors
- Receives $50,000 in research funding, expert mentoring from J&J, and access to a global network
LN Robotics, a company specializing in AI and medical robotics, announced that it has won the inaugural Korea Innovation QuickFire Challenge, hosted by JLABS Korea, Johnson & Johnson Innovation’s startup incubation program.
The Korea Innovation QuickFire Challenge was launched in May 2024 after South Korea’s Ministry of Health and Welfare selected Johnson & Johnson Innovation–JLABS as the lead operator of its global accelerator platform. The challenge sought groundbreaking healthcare technologies in robotics, digital health, and bio-medical devices, providing prize funds to support meaningful progress for innovative companies.
In the challenge, LN Robotics presented ‘AVIAR’, the first robotic assistant for coronary intervention developed in South Korea, along with its core technologies. The coronary arteries supply blood to the heart muscle, and narrowing of these arteries due to conditions like hypertension, diabetes, and hyperlipidemia can lead to serious diseases such as angina and myocardial infarction. Coronary interventions, including balloon angioplasty, are performed to treat such conditions. AVIAR provides precise surgical assistance with millimeter-level control. Additionally, since X-ray imaging is used during procedures, exposing medical staff to radiation, AVIAR helps minimize radiation exposure for healthcare professionals.
LN Robotics earned high scores based on the challenge’s key evaluation criteria, including the uniqueness of the idea, feasibility, and potential impact on human health. The company was particularly praised for its creative application of AI and its strong competitiveness in cardiovascular intervention robotics compared to global competitors.
Unlike other international competitors, AVIAR features a multi-channel surgical tool control system that supports a broad range of procedures, including complex interventions. It also includes a haptic feedback device that enhances precision and accuracy in tool manipulation. Furthermore, its AI-driven capabilities assist medical professionals by displaying essential procedural data, analyzing vascular curvature, and detecting potential anomalies in real time.
An LN Robotics representative stated, "AVIAR integrates cutting-edge AI technologies to enhance intelligence, precision, speed, and ease of control in complex percutaneous coronary intervention (PCI) procedures. With this award, we will strive to grow into a company that brings real change and support to the global medical device industry, healthcare professionals, and patients worldwide.”
As a winner of the Korea Innovation QuickFire Challenge, LN Robotics will receive $50,000 (approximately 71 million KRW) in research funding and membership to JLABS Korea. The company will also benefit from mentorship by Johnson & Johnson experts and gain access to the global JLABS network, fostering connections with international entrepreneurial communities.